CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Active Treatment Improves Overall Survival in Extremely Older Non–Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study
Su Yeon Lee, Yoon-Ki Hong, Wonjun Ji, Jae Cheol Lee, Chang Min Choi, ,
Cancer Research and Treatment. 2021;53(1):104-111.   Published online 2020 October 5    DOI: https://doi.org/10.4143/crt.2020.894

Excel Download

Active Treatment Improves Overall Survival in Extremely Older Non–Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study
Cancer Research and Treatment. 2021;53(1):104-111   Crossref logo
Link1 Link2 Link3

Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study
Journal of Cancer Research and Clinical Oncology. 2020;147(1):287-293   Crossref logo
Link1 Link2 Link3

CLC036 POSTER Relationship between age treatment and overall survival in patients with non-small cell lung cancer (NSCLC)
Lung Cancer. 2007;55:S10   Crossref logo
Link1 Link2

Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients)
Lung Cancer. 1996;14(2-3):408   Crossref logo
Link1 Link2

Real-world data on management of brain metastases in non-small cell lung cancer, Queen Elizabeth Hospital, Birmingham: a retrospective study on progression free survival, overall survival of different treatment modalities for brain metastases and prevalence of brain metastases in NSCLC receiving immunotherapy
Lung Cancer. 2020;139:S51   Crossref logo
Link1 Link2

Immunotherapy drug improves survival of patients with squamous non-small cell lung cancer
Cancer. 2015;121(20):3562-3563   Crossref logo
Link1 Link2

ANALYSIS OF POST-NIVOLUMAB TREATMENT IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE SINGLE INSTITUTION STUDY
Respirology. 2017;22:114-114   Crossref logo
Link1 Link2

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients
ESMO Open. 2021;6(1):100013   Crossref logo
Link1 Link2

Subcutaneous heparin treatment increases complete response rate and overall survival in small cell lung cancer (SCLC)
Lung Cancer. 1991;7:129   Crossref logo
Link1 Link2

Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non–small-cell Lung Cancer: A Retrospective Study
Clinical Lung Cancer. 2018;19(5):e629-e645   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.